{"id":"https://openalex.org/W4409688902","doi":"https://doi.org/10.1158/1538-7445.am2025-1560","title":"Abstract 1560: SCR-A0011, a novel bispecific ADC targeting cMET and B7H3, exhibits potent anti-tumor efficacy","display_name":"Abstract 1560: SCR-A0011, a novel bispecific ADC targeting cMET and B7H3, exhibits potent anti-tumor efficacy","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409688902","doi":"https://doi.org/10.1158/1538-7445.am2025-1560"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-1560","doi":"https://doi.org/10.1158/1538-7445.am2025-1560","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1560","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033611704","display_name":"Yayuan Fu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yayuan Fu","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014351234","display_name":"Guangcun Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guangcun Cheng","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006165634","display_name":"Hui Zheng","orcid":"https://orcid.org/0000-0001-6801-0529","observed_orcids":["https://orcid.org/0000-0001-6801-0529","https://orcid.org/0000-0003-2930-4641"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Zheng","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shuai Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuai Wang","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040453440","display_name":"Lei Jiang","orcid":"https://orcid.org/0000-0002-2922-0707","observed_orcids":["https://orcid.org/0000-0002-2922-0707"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Jiang","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102716803","display_name":"Chunlei Xia","orcid":"https://orcid.org/0000-0002-2138-7780","observed_orcids":["https://orcid.org/0000-0002-2138-7780"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunlei Xia","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Huipeng Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huipeng Guo","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101509953","display_name":"Xiyuan Wang","orcid":"https://orcid.org/0000-0002-2639-076X","observed_orcids":["https://orcid.org/0000-0002-2639-076X","https://orcid.org/0009-0004-9667-4102"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiyuan Wang","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112841401","display_name":"Renhong Tang","orcid":"https://orcid.org/0009-0005-3494-707X","observed_orcids":["https://orcid.org/0009-0005-3494-707X","https://orcid.org/0000-0003-2560-8437"]},"institutions":[{"id":"https://openalex.org/I4210096870","display_name":"Simcere Pharmaceutical (China)","ror":"https://ror.org/00t01w369","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096870"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Renhong Tang","raw_affiliation_strings":["Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simcere Zaiming, State Key Laboratory of Neurology and Oncology Drug Development. Simcere Pharmaceutical Group, Shanghai, China","institution_ids":["https://openalex.org/I4210096870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210096870"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"1560","last_page":"1560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibody-drug-conjugate","display_name":"bispecific antibody-drug conjugate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.9359999895095825},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":1.0},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7170000076293945},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7210000157356262},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8790000081062317},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.753000020980835},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.58980792760849},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5055115222930908},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3308897614479065},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32623326778411865}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-1560","doi":"https://doi.org/10.1158/1538-7445.am2025-1560","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1560","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2],"HGF/cMET":[3],"signaling":[4,73],"pathway":[5],"plays":[6],"an":[7],"important":[8],"role":[9],"in":[10,26,47,57,71,113,122,138,193,204,220,224,242,277,295],"the":[11,82,194,270,296,335],"regulation":[12],"of":[13,42,50,116,159,274,334],"cell":[14,197,202,207],"proliferation,":[15],"differentiation,":[16],"migration":[17],"and":[18,40,86,103,109,129,135,174,179,183,254,281,290,325],"other":[19],"normal":[20,29,123],"physiological":[21],"functions.":[22],"cMET":[23,43,52,72,108,130,175,291,324],"is":[24,32,53,63,157],"expressed":[25,34],"many":[27],"different":[28],"tissues":[30],"but":[31,59],"usually":[33],"at":[35],"low":[36],"levels.":[37],"Abnormal":[38],"expression":[39,78,121],"dysfunction":[41],"have":[44,250],"been":[45],"found":[46],"a":[48,54,133,146,225,264,284,319],"variety":[49],"tumors.":[51,79],"well-established":[55],"target":[56],"clinical,":[58],"its":[60],"clinical":[61,66,240],"application":[62],"limited,":[64],"because":[65],"efficacy":[67,219,330],"was":[68],"mainly":[69],"observed":[70],"driving":[74],"tumor":[75,201,206,246],"or":[76,239,272],"cMET-high":[77],"To":[80],"extend":[81],"potential":[83,265],"therapeutic":[84,286],"population":[85],"anti-tumor":[87,218,233,329],"activity,":[88],"we":[89],"searching":[90],"for":[91,288,338],"some":[92],"new":[93,134,285],"approaches,":[94],"such":[95],"as":[96],"bispecific":[97,150,161,321],"antibody":[98,162,190],"drug":[99],"conjugates.":[100],"Bioinformatics":[101],"analysis":[102],"translational":[104],"research":[105],"showed":[106,180,216],"that":[107],"B7H3":[110,128,173,289],"are":[111],"co-expressed":[112],"multiple":[114],"types":[115,208,280],"solid":[117],"tumors":[118],"without":[119],"high":[120,177],"tissues.":[124],"Therefore,":[125],"targeting":[126,323],"both":[127],"could":[131,262],"be":[132,263],"powerful":[136],"strategy":[137],"pan-tumor":[139],"therapy.":[140],"Methods":[141],"&":[142],"Results:":[143],"We":[144],"developed":[145],"novel":[147,165,320],"B7H3xcMET":[148],"targeted":[149],"antibody-drug":[151],"conjugate":[152],"(ADC)":[153],"called":[154],"SCR-A0011,":[155,318],"which":[156],"comprised":[158],"B7H3/cMET":[160,195],"conjugated":[163],"with":[164,176],"topoisomerase":[166],"1":[167,345],"inhibitor":[168],"(CPT116).":[169],"SCR-A0011":[170,199,215,229,248],"specifically":[171],"bind":[172],"affinity,":[178],"enhanced":[181],"internalization":[182],"binding":[184],"capacity":[185],"compared":[186],"to":[187,268],"parental":[188,237],"monoclonal":[189],"ADC":[191,241,322],"separately":[192],"co-expressing":[196],"line.":[198],"induced":[200],"lysis":[203],"various":[205],"including":[209],"NSCLC,":[210],"CRC,":[211],"OC,":[212],"HNSCC,":[213],"etc.":[214],"remarkable":[217],"several":[221],"CDX":[222],"models":[223],"dose":[226],"dependent":[227],"manner.":[228],"exhibits":[230,327],"significantly":[231],"stronger":[232],"activity":[234],"than":[235],"their":[236],"monoclonal-ADC":[238],"B7H3+cMET+":[243],"double":[244],"positive":[245,292],"cells.":[247],"also":[249],"very":[251],"good":[252],"stability":[253],"favorable":[255],"developability.":[256],"Conclusion:":[257],"These":[258],"findings":[259],"illustrated":[260],"SCR-A011":[261],"First-in-Class":[266],"BsADC":[267],"conquer":[269],"resistance":[271],"non-response":[273],"current":[275],"treatment":[276],"broad":[278],"cancer":[279,293],"may":[282],"provide":[283],"approach":[287],"patients":[294],"future.":[297],"Citation":[298],"Format:":[299],"Yayuan":[300],"Fu,":[301],"Guangcun":[302],"Cheng,":[303],"Hui":[304],"Zheng,":[305],"Shuai":[306],"Wang,":[307,315],"Lei":[308],"Jiang,":[309],"Chunlei":[310],"Xia,":[311],"Huipeng":[312],"Guo,":[313],"Xiyuan":[314],"Renhong":[316],"Tang.":[317],"B7H3,":[326],"potent":[328],"[abstract].":[331],"In:":[332],"Proceedings":[333],"American":[336],"Association":[337],"Cancer":[339,356],"Research":[340],"Annual":[341],"Meeting":[342],"2025;":[343],"Part":[344],"(Regular":[346],"Abstracts);":[347],"2025":[348],"Apr":[349],"25-30;":[350],"Chicago,":[351],"IL.":[352],"Philadelphia":[353],"(PA):":[354],"AACR;":[355],"Res":[357],"2025;85(8_Suppl_1):Abstract":[358],"nr":[359],"1560.":[360]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}